Phase 2 Reduction of Dietary Mycotoxin Exposure by ACCS100"

NCT01677195 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

234

Enrollment

INDUSTRY

Sponsor class

Conditions

Dietary Carcinogenesis

Interventions

DRUG: ACCS100
DRUG: Placebo

Sponsor

Texas Enterosorbents Incorporated

Collaborators

[object Object]
[object Object]
[object Object]